|
|
|
Insider
Information: |
Smith Sandford D |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
386,982 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$925,106 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
386,982 |
|
|
Total
Value |
$925,106 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-24.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ariad Pharmaceuticals Inc |
ARIA |
Director |
2007-06-20 |
131,205 |
2004-01-15 |
0 |
Premium* |
|
Genzyme Corp |
GENZ |
Exe VP,President Intl ... |
2011-04-04 |
0 |
2005-07-29 |
0 |
Premium* |
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2013-08-09 |
0 |
Premium* |
|
Palisade Bio Inc |
PALI |
Director |
2019-07-01 |
219,916 |
|
0 |
Premium* |
|
Seelos Therapeutics Inc |
SEEL |
Director |
2017-01-05 |
16,160 |
2014-10-22 |
0 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-01-27 |
900 |
2016-11-29 |
0 |
Premium* |
|
Cytokinetics Inc |
CYTK |
Director |
2024-01-02 |
18,801 |
2020-06-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYTK |
Cytokinetics Inc |
Director |
|
2020-10-05 |
4 |
AS |
$30.00 |
$178,080 |
D/D |
(5,936) |
0 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-10-05 |
4 |
OE |
$7.37 |
$43,748 |
D/D |
5,936 |
5,936 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-06-15 |
4 |
S |
$22.00 |
$146,652 |
D/D |
(6,666) |
0 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-06-15 |
4 |
OE |
$6.30 |
$41,996 |
D/D |
6,666 |
6,666 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-07-15 |
4 |
AS |
$29.00 |
$193,343 |
D/D |
(6,667) |
0 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-07-15 |
4 |
OE |
$6.21 |
$41,402 |
D/D |
6,667 |
6,667 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-06-17 |
4 |
S |
$23.00 |
$158,861 |
D/D |
(6,907) |
0 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-06-17 |
4 |
OE |
$6.78 |
$46,994 |
D/D |
6,907 |
2,741 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2016-06-30 |
4 |
A |
$0.40 |
$3,250 |
D/D |
8,136 |
39,486 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2014-10-22 |
4 |
B |
$1.52 |
$12,651 |
D/D |
8,300 |
8,300 |
2.39 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2013-08-09 |
4 |
S |
$92.33 |
$781,414 |
D/D |
(8,463) |
1,537 |
0 |
- |
|
GENZ |
Genzyme Corp |
Exe VP,President Intl Group |
|
2010-05-25 |
4 |
S |
$45.60 |
$405,292 |
D/D |
(8,887) |
20,671 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2016-09-30 |
4 |
A |
$0.34 |
$3,250 |
D/D |
9,607 |
49,093 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-04-27 |
4 |
OE |
$10.55 |
$103,396 |
D/D |
9,739 |
5,920 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-04-27 |
4 |
AS |
$27.50 |
$270,323 |
D/D |
(9,739) |
920 |
0 |
% |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2004-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
0 |
|
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2004-11-29 |
4 |
OE |
$2.00 |
$20,000 |
D/D |
10,000 |
66,205 |
|
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2005-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
76,205 |
|
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
officerTitle |
|
2005-12-01 |
4 |
OE |
$3.63 |
$36,300 |
D/D |
10,000 |
86,205 |
|
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2013-08-09 |
4 |
OE |
$15.00 |
$160,518 |
D/D |
10,000 |
10,000 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-06-22 |
4 |
OE |
$4.44 |
$44,400 |
D/D |
10,000 |
5,000 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-06-22 |
4 |
S |
$24.00 |
$245,000 |
D/D |
(10,000) |
0 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-04-15 |
4 |
AS |
$25.00 |
$270,350 |
D/D |
(10,714) |
920 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-04-15 |
4 |
OE |
$8.75 |
$97,248 |
D/D |
10,714 |
6,634 |
0 |
- |
|
GENZ |
Genzyme Corp |
Executive Vice President |
|
2006-08-31 |
4 |
S |
$66.23 |
$738,133 |
D/D |
(11,145) |
6,305 |
|
- |
|
113 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|